Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome

References

• Agrawal, V., Sangwan, V., & Fernandez, M. (2006). Clinical handbook of dry eye. India: Ophthalmic Communications.
   Google Scholar
• Albietz, J. M., Lenton, L. M., McLennan, S. G., & Earl, M. L. (2002). A, Comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients. The CLAO Journal, 28, 96–100.
   PubMedGoogle Scholar
• Byun, Y. J., Kim, T. I., Kwon, S. M., Seo, K. Y., Kim, S. W., Kim, E. K., & Park, W. C. (2009, August 31). Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye. Cornea, 31, 509–513.
   Web of Science ®Google Scholar
• Gilbard, J. P. (2000). Dry eyes syndrome. In D. Albert & F. Jakobiec (Eds.), Principles & practice of ophthalmology (2nd ed., pp. 982–1001). Pennsylvania, PA: Saunders.
   Google Scholar
• Kim, E. C., Choi, J. S., & Joo, C. -K. (2009). A comparison of vitamin A and cyclosporine A 0.05% eye drops for treatment of dry eye syndrome. American Journal of Ophthalmology, 147, 206–213.10.1016/j.ajo.2008.08.015
   PubMed Web of Science ®Google Scholar
• Kinoshita, S., Kiorpes, T. C., Friend, J., & Thoft, R. A. (1983). Goblet cell density in ocular surface disease. A better indicator than tear mucin. Archives of Ophthalmology, 101, 1284–1287.10.1001/archopht.1983.01040020286025
   PubMedGoogle Scholar
• Kunert, K. S., Tisdale, A. S., & Gipson, I. K. (2002). Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Archives of Ophthalmology, 120, 330–337.10.1001/archopht.120.3.330
   PubMed Web of Science ®Google Scholar
• Lee, J. H., Ahn, H. S., Kim, E. K., & Kim, T. I. (2011). Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea, 30, 175–179.10.1097/ICO.0b013e3181e9adcc
   PubMed Web of Science ®Google Scholar
• Lemp, M. A. (1995). Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO Journal, 21, 221–232.
   PubMedGoogle Scholar
• Moon, J. W., Lee, H. J., Shin, K. C., Wee, W. R., Lee, J. H., & Kim, M. K. (2007). Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Korean Journal of Ophthalmology, 21, 189–194.10.3341/kjo.2007.21.4.189
   PubMedGoogle Scholar
• Morales-Fernández, L., Pérez-Álvarez, J., García-Catalán, R., Benítez-del-Castillo, J. M., & García-Sánchez, J. (2010). Clinical-histological correlation in patients with dry eye. Archivos de la Sociedad Española de Oftalmología, 85, 239–245.10.1016/j.oftal.2010.07.002
   PubMedGoogle Scholar
• Pflugfelder, S. C., De Paiva, C. S., Villarreal, A. L., & Stern, M. E. (2008). Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-B2 production. Cornea, 27, 64–69.10.1097/ICO.0b013e318158f6dc
   PubMed Web of Science ®Google Scholar
• Sahli, E., Hoşal, B. M., Zilelioğlu, G., Gülbahçe, R., & Üstün, H. (2010). The effect of topical cyclosporine a on clinical findings and cytological grade of the disease in patients with dry eye. Cornea, 29, 1412–1416.10.1097/ICO.0b013e3181e7845b
   PubMed Web of Science ®Google Scholar
• Saini, J. S., Rajwanshi, A., & Dhar, S. (1990). Clinicopathological correlation of hard contact lens related changes in tarsal conjunctiva by impression cytology. Acta Ophthalmologica, 68, 65–70.
   Web of Science ®Google Scholar
• Sall, K., Stevenson, O. D., Mundorf, T. K., Reis, B. L., & The CsA Phase 3 Study Group (2000). Two mulicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology, 107, 631–639.
   PubMed Web of Science ®Google Scholar
• Sall, K., Cohen, S., & Christensen, M. (2006). An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marked artificial tears as a supportive therapy in dry eye. Eye & Contact Lens: Science & Clinical Practice, 32, 21–26.10.1097/01.icl.0000170599.57728.29
   PubMedGoogle Scholar
• Shah, D., Lavangia B. C., Billore, O. P., Sivasane, S., Das, S., Yagnik, H., & Desai, R. (2008). Beneficial effect of cyclosporine-A on dry ocular surface: Evaluation of 56 eyes with conjunctival impression cytology (CIC) and rose Bengal stain score (RBSS). In AIOC 2008 Proceedings Cornea Session II (pp. 180–182).
   Google Scholar
• Small, D. S., Acheampong, A., Reis, B., Stern, K., Stewart, W., Berdy, G., … Tang-Liu, D. D.-S. (2002). Blood concentrations of cyclosporine A during long-term treatment with cylcosporin A ophthalmic emulsions in patients with moderate to severe dry eye disease. Journal of Ocular Pharmacology and Therapeutics, 18, 411–418.10.1089/10807680260362696
   PubMed Web of Science ®Google Scholar
• Stevenson, D., Tauber, J., & Reis, B. L. (2000). Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate–to–severe dry eye disease: A dose–ranging, randomized trial. The cyclosporin A phase 2 study group. Ophthalmology, 107, 967–974.10.1016/S0161-6420(00)00035-X
   PubMed Web of Science ®Google Scholar
• Strong, B., Farley, W., Stern, M. E., & Pflugfelder, S. C. (2005). Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjnctivitis sicca. Cornea, 24, 80–85.10.1097/01.ico.0000133994.22392.47
   PubMed Web of Science ®Google Scholar